Evaluation of Depression and Anxiety in Chemotherapy Patients

Description

This study will examine the existence and severity of depression and anxiety in patients undergoing chemotherapy at RUMC. Patients currently undergoing initial chemotherapy cycle will be compared to patients undergoing a subsequent chemotherapy cycle. Data will then be collected using standardized depression and anxiety scales to assess if these comorbidities exist and to what severity level. Data already collected for depression and anxiety in patients with chronic, but not cancer, illness will be used as a control. The participants will be screened for signs of psychological distress using three self administered questionnaires: the Generalized Anxiety Disorder 7 item Scale (GAD7) and Patient Health Questionnaire (PHQ9). Demographic information about the participants, including medical and psychiatric history, will also be gathered from their medical records.

Conditions

Oncology Problem

Study Overview

Study Details

Study overview

This study will examine the existence and severity of depression and anxiety in patients undergoing chemotherapy at RUMC. Patients currently undergoing initial chemotherapy cycle will be compared to patients undergoing a subsequent chemotherapy cycle. Data will then be collected using standardized depression and anxiety scales to assess if these comorbidities exist and to what severity level. Data already collected for depression and anxiety in patients with chronic, but not cancer, illness will be used as a control. The participants will be screened for signs of psychological distress using three self administered questionnaires: the Generalized Anxiety Disorder 7 item Scale (GAD7) and Patient Health Questionnaire (PHQ9). Demographic information about the participants, including medical and psychiatric history, will also be gathered from their medical records.

Evaluation of Depression and Anxiety in Chemotherapy Patients

Evaluation of Depression and Anxiety in Chemotherapy Patients

Condition
Oncology Problem
Intervention / Treatment

-

Contacts and Locations

Staten Island

Richmond University Medical Center, Staten Island, New York, United States, 10310

Staten Island

Richmond University Medical Center, Staten Island, New York, United States, 10310

Staten Island

Richmond University Medical Center, Staten Island, New York, United States, 10310

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients unable to give informed consent.
  • * Patients with a previous diagnosis of anxiety or depression prior to chemotherapy

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Richmond University Medical Center,

Jakey Patwari, MD, STUDY_DIRECTOR, Richmond University Medical Center

Study Record Dates

2025-12-20